Company Overview and News

2
tronc, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-11 seekingalpha
The following slide deck was published by tronc, Inc. in conjunction with their 2018 Q2 earnings call.
TRNC

2
The Tronc Earnings Report Still Takes a Backseat to Buyout Whispers

2018-08-11 investorplace
To the extent Tronc (NASDAQ:TRNC) can be handicapped, the analyst community did a pretty good job of figuring out how well the newspaper company did during the second quarter of the year.
TRNC

2
53
6 Most Important Things In Business Today

2018-08-10 247wallst
The housing market hit a sudden and “significant” slowdown in the past few weeks that could continue in coming months, Redfin Corp.’s chief executive said Thursday afternoon.
RDFN AAPL BC94 TSLA SMSN TRNC 9984 SFTBF SFTBY SMSD

2
tronc, Inc. (TRNC) CEO Justin Dearborn on Q2 2018 Results - Earnings Call Transcript

2018-08-09 seekingalpha
Good afternoon, and welcome to the tronc, Inc. Second Quarter 2018 Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded.
TRNC

2
TRNC / tronc, Inc. FORM 8-K (Current Report)

2018-08-09 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ Form 8-K _____________________ CURRENT REPORT
TRNC

2
TRNC / tronc, Inc. S-3/A

2018-08-01 sec.gov
Table of Contents As filed with the Securities and Exchange Commission on August 1, 2018
TRNC

2
tronc, Inc. to Report Second Quarter 2018 Results on August 9, 2018

2018-07-31 globenewswire
CHICAGO, July 31, 2018 (GLOBE NEWSWIRE) -- tronc, Inc. (NASDAQ:TRNC) will report its financial results for the second quarter ended July 1, 2018 on Thursday, August 9, 2018 after the market closes.
TRNC

2
Chicago Tribune and Anthony Rizzo Launch “Cancer Can’t Compete” Campaign

2018-07-24 globenewswire
CHICAGO, July 24, 2018 (GLOBE NEWSWIRE) -- Chicago Cubs’ Anthony Rizzo and the Chicago Tribune today launched “Cancer Can’t Compete,” a new campaign to inspire Chicago area families battling cancer and raise funds for cancer research. In partnership with Mariano’s and the University of Chicago Medicine, the initiative will spotlight Chicago area patients and families who are fighting cancer and share the reality of their battles in stories run by the Chicago Tribune.
TRNC

12
6 Most Important Things In Business Today

2018-07-24 247wallst
The Google search unit of Alphabet Inc (NASDAQ: GOOGL) posted earnings results which were much larger than the possible effects of a fine from the EU. According to The Wall Street Journal:
NKE GOOGL TRNC NYTAB GOOG

7
Papa John’s Board Votes to Adopt ‘Poison Pill’ Against Founder - WSJ

2018-07-23 wsj
Papa John’s International Inc.’s PZZA -6.24% board members voted to adopt a “poison pill” on Sunday to prevent its controversial founder from gaining a controlling interest in the pizza chain, according to people familiar with the matter.
TRNC CAR TPUB

8
Papa John’s Board to Discuss ‘Poison Pill’ to Block Founder From Gaining Control - WSJ

2018-07-22 wsj
Papa John’s International Inc. PZZA 1.16% board members are planning to discuss and possibly vote Sunday morning on whether to adopt a “poison pill” to prevent its controversial founder from gaining a controlling interest in the pizza chain, according to people familiar with the matter.
TRNC CAR TPUB

3
Harte Hanks Appoints a New Independent Director to its Board

2018-07-09 globenewswire
SAN ANTONIO, July 09, 2018 (GLOBE NEWSWIRE) -- Harte Hanks (NYSE:HHS) today announced it has appointed John H. “Jack” Griffin, Jr. to its Board of Directors, effective July 5, 2018, to fill the seat held by William F. Farley, whose resignation was previously announced and became effective upon Mr. Griffin’s appointment.
HHS TRNC NYTAB TPUB

2
tronc Margins And Stock Price Likely Headed Lower

2018-07-06 seekingalpha
Editor's note: Seeking Alpha is proud to welcome Overdue Diligence as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
TRNC

2
Tronc Margins & Stock Price Likely Headed Lower

2018-07-06 seekingalpha
Editor's note: Seeking Alpha is proud to welcome Overdue Diligence as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
TRNC

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 896082104